Laboratory research published in Circulation identifies how diabetes may worsen heart complications through disruption of cannabinoid receptor 2 function. This diabetic heart disease cannabinoid receptor research provides mechanistic insights but requires clinical validation before therapeutic applications.
A sesquiterpene-rich essential oil from Cannabis sativa L. attenuates symptoms and neuroinflammation in experimental autoimmune encephalomyelitis model through a CB2-mediated signalling.
Researchers found that cannabis essential oil neuroinflammation reduction occurred through CB2 receptor activation in an experimental multiple sclerosis model. The sesquiterpene-rich formulation improved pain, motor function, and emotional symptoms without psychoactive effects. While promising, this preclinical evidence requires human validation before clinical application.
Assessments of Evoked and Spontaneous Pain Following Administration of Gabapentin and the Cannabinoid CB
A preclinical study demonstrates that CB2 receptor agonist neuropathic pain treatment may address both mechanical hypersensitivity and spontaneous pain components. While promising mechanistically, this research requires human validation before clinical application.
(โ)-ร-Caryophyllene, a Terpine Found in Cannabis, Demonstrates Therapeutic Potential in a Mouse Model of MS
(โ)-ฮฒ-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis In Summary Multiple sclerosis (MS) is a central nervous system disease whose inflammatory and other...